Pharma & Life Sciences in China

From drug registration to post-market pharmacovigilance — plain-English guidance on the full regulatory lifecycle for pharmaceutical, biotech and medical-device companies doing business in China, and the lawyers who handle it.

The Regulatory Context

Why pharma needs specialist legal support

Pharmaceuticals is one of the most heavily regulated, highest-risk sectors in China. A single misstep can carry administrative penalties, criminal liability and massive civil claims — often all at once.

📜

200+ regulations

Specialised rules and normative documents governing the pharma sector at national level.

🧬

Full lifecycle coverage

Core compliance areas spanning a drug's entire life from R&D to market withdrawal.

⚖️

Administrative + criminal

Anti-corruption and counterfeiting cases routinely cross from fines into criminal prosecution.

🌏

Cross-border intensity

Import, MRCT, HGR and data-transfer rules tie China operations to global compliance (FCPA, UKBA).

Practice Areas

Core pharma & life sciences services

Nine practice areas covering a drug's full lifecycle in China.

In-Depth Insights

Deeper dives into the areas that trip companies up

Risk Scenarios

High-risk scenarios & legal consequences

Pharma compliance risk spans administrative, civil and criminal liability. These are the scenarios we see most often.

ScenarioConductRiskLegal consequence
Kickbacks / rebates Paying doctors rebates or kickbacks tied to prescribing volume, or funnelling benefits through sham services. Criminal Bribery of non-state functionaries (PRC Criminal Law Art. 164) and acceptance of bribes (Art. 163); both the company and individuals can face criminal liability of up to 10+ years.
Clinical data falsification Fabricating or altering trial data, selective reporting of results, or concealing adverse events. Criminal Admin Refusal or revocation of drug registration (administrative); the crime of providing false supporting documents (Art. 229); a 3-year bar on further trial applications.
Manufacturing counterfeit / substandard drugs Producing products that fail drug standards, passing non-drugs off as drugs, or adding undeclared active ingredients. Criminal The crimes of producing or selling counterfeit drugs (Art. 141) and substandard drugs (Art. 142), with fines of 2×+ of sales value; the counterfeit-drug offence carries a possible death penalty.
Failure to report serious adverse reactions Not reporting serious adverse reactions to the drug authority within the statutory time limit. Admin Fines of CNY 50,000–500,000; in serious cases, suspension of production or revocation of the approval document and manufacturing licence.
Non-compliant advertising Advertising prescription drugs to the public, or publishing false or misleading drug ads without review. Admin Civil Heavy administrative fines (up to 5× the advertising fee); civil liability — consumers may claim treble damages under the Consumer Protection Law.
Unauthorised HGR export Providing Chinese genetic data or biological samples to foreign parties without approval or filing. Admin Criminal Ministry of Science & Technology sanctions — suspension of projects or revocation of approvals; serious cases may be referred for criminal prosecution (Art. 334-1).
Post-VBP supply default Failing to supply after winning a tender without good cause, selective supply, or lowering quality standards. Admin Civil Placement on the "violation list" and loss of VBP eligibility for all products for a set period; liability to hospitals for breach of the supply contract.
How We Work

How we support pharma clients

1

Risk assessment & diagnosis

A full compliance scan of your operations, identifying key risks and delivering a written assessment.

2

Program design

Tailored compliance programs and executable SOPs built around both regulation and commercial goals.

3

Training & rollout

Layered compliance training for management and key roles so the program becomes part of daily operations.

4

Ongoing & crisis response

Ongoing counsel that tracks regulatory change and steps in first when a crisis hits.

Need a lawyer for pharma & life sciences in China?

Tell us your situation — a specialist lawyer will reach out within one business day.

Submit Request →